CXCL8 and neoplasm: Given the frequency at which αvβ6 is overexpressed in solid tumors and the prevalence of IL-8 production in the tumor microenvironment, this provides a strong rationale for combining highly tumor-specific CAR T-cells with chemokine receptors to improve homing and therapeutic activity.